Elbasha E - Search Results

1

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R. Jit M, et al. Among authors: elbasha e. BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.

2

Structural differences among cost-effectiveness models of human papillomavirus vaccines.

Insinga RP, Dasbach EJ, Elbasha EH. Insinga RP, et al. Expert Rev Vaccines. 2008 Sep;7(7):895-913. doi: 10.1586/14760584.7.7.895. Expert Rev Vaccines. 2008. PMID: 18767941 Free article.

3

The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.

Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha EH. Dasbach EJ, et al. Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):459-66. Asian Pac J Cancer Prev. 2008. PMID: 18990021 Free article.

4

The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary.

Dasbach EJ, Nagy L, Brandtmüller A, Elbasha EH. Dasbach EJ, et al. J Med Econ. 2010 Mar;13(1):110-8. doi: 10.3111/13696990903546013. J Med Econ. 2010. PMID: 20085477 Free article.

5

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.

Dasbach EJ, Elbasha EH, Insinga RP. Dasbach EJ, et al. Epidemiol Rev. 2006;28:88-100. doi: 10.1093/epirev/mxj006. Epub 2006 Jun 1. Epidemiol Rev. 2006. PMID: 16740585 Review.

6

Model for assessing human papillomavirus vaccination strategies.

Elbasha EH, Dasbach EJ, Insinga RP. Elbasha EH, et al. Emerg Infect Dis. 2007 Jan;13(1):28-41. doi: 10.3201/eid1301.060438. Emerg Infect Dis. 2007. PMID: 17370513 Free PMC article.

7

Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation.

Insinga RP, Dasbach EJ, Elbasha EH, Puig A, Reynales-Shigematsu LM. Insinga RP, et al. Vaccine. 2007 Dec 21;26(1):128-39. doi: 10.1016/j.vaccine.2007.10.056. Epub 2007 Nov 20. Vaccine. 2007. PMID: 18055075

8

The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK.

Dasbach EJ, Insinga RP, Elbasha EH. Dasbach EJ, et al. Among authors: elbasha eh. BJOG. 2008 Jul;115(8):947-56. doi: 10.1111/j.1471-0528.2008.01743.x. Epub 2008 May 22. BJOG. 2008. PMID: 18503574

9

Vaccination and the evolutionary ecology of human papillomavirus.

Poolman EM, Elbasha EH, Galvani AP. Poolman EM, et al. Vaccine. 2008 Jul 18;26 Suppl 3:C25-30. doi: 10.1016/j.vaccine.2008.04.010. Vaccine. 2008. PMID: 18773535

10

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Insinga RP, Dasbach EJ, Elbasha EH. Insinga RP, et al. BMC Infect Dis. 2009 Jul 29;9:119. doi: 10.1186/1471-2334-9-119. BMC Infect Dis. 2009. PMID: 19640281 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters